According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -$2.56. In 2022 the company made an earnings per share (EPS) of -$3.13 a decrease over its 2021 EPS that were of -$2.93.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.32 | -25.63% |
2022 | -$3.13 | 6.78% |
2021 | -$2.93 | -41.04% |
2020 | -$4.97 | 130.75% |
2019 | -$2.15 |